Home>Topics>>The Future Is Bright For Arena Pharmaceuticals
The Future Is Bright For Arena Pharmaceuticals
Long Investing Ideas from Seeking Alpha
Mon, 26 Nov 2012
By Demetri Mallios : This summer, the FDA took action to make Arena Pharmaceuticals' ( ARNA ) Belviq the first drug approved for the treatment of obesity in thirteen years. By now, most are aware that Belviq's main competition is Vivus' ( VVUS ) Qsymia, and this has led to a sharp divide in ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.